3M (MMM)
(Delayed Data from NYSE)
$96.35 USD
+0.81 (0.85%)
Updated May 8, 2024 04:00 PM ET
After-Market: $96.35 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
D Value A Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$96.35 USD
+0.81 (0.85%)
Updated May 8, 2024 04:00 PM ET
After-Market: $96.35 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
D Value A Growth B Momentum B VGM
Zacks News
Conglomerate 3M’s focus on business transformation — with moves like the localization of decision making and integration of supply chains — enhances its competitive advantage. Also, its recognized product brands and investments in innovation are compelling. Inorganic actions (buyouts and divestments) are added advantages. Acelity, bought in October 2019, is predicted to aid 3M’s medical solutions business. Being one of the largest manufacturers of respiratory masks, the coronavirus outbreak has added to the company’s growth potential.
3M Poised for Solid Growth on Diligent Execution of Plans
by Zacks Equity Research
3M Company (MMM) recently debriefed investors about its diligent execution of the core strengths that are likely to fuel its growth in 2017 and beyond.
The Zacks Analyst Blog Highlights: Goldman Sachs Group, JPMorgan, 3M and IBM
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Goldman Sachs Group, JPMorgan, 3M and IBM
3M (MMM) Divests Identity Management Business to Gemalto
by Zacks Equity Research
3M Company (MMM) recently entered into a strategic agreement to divest its identity management business to Gemalto, an international digital security company.
3M (MMM) to Divest Safety Prescription Eyewear Unit to HOYA
by Zacks Equity Research
3M Company (MMM) recently inked a definitive agreement with HOYA Vision Care, a premier eyeglass lens provider across the globe, to divest its prescription eyewear business for an undisclosed amount.
Stock Market News for November 25, 2016
by Zacks Equity Research
by Zacks Equity Research
Stock Market News for October 26, 2016
by Zacks Equity Research
A spate of disappointing quarterly reports dragged the major indexes down on Tuesday.
New Research Reports for Pepsi, Philips Morris & Dow Chemical
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Pepsi (PEP), Philip Morris (PM) and Dow Chemical (DOW).
Stock Market News for July 27, 2016
by Zacks Equity Research
Q2 Earnings Season Opens the Spigot: MCD, VZ, CAT & More
by Mark Vickery
Following a first couple weeks of a mostly positive trickle of earnings reports released, we've now opened the tap fully.